Depression, Antidepressant Use May Up Risk of A-Fib

Share this content:
Depression, Antidepressant Use May Up Risk of A-Fib
Depression, Antidepressant Use May Up Risk of A-Fib

THURSDAY, March 22, 2018 (HealthDay News) -- Depression and antidepressant use are associated with atrial fibrillation (AF), according to a study presented at the American Heart Association's Epidemiology and Prevention/Lifestyle and Cardiometabolic Health 2018 Scientific Sessions, held from March 20 to 23 in New Orleans.

Parveen K. Garg, M.D., M.P.H., from the Keck School of Medicine at the University of Southern California in Los Angeles, and colleagues examined the correlation of depressive symptoms and antidepressant use with incident AF in the Multi-Ethnic Study of Atherosclerosis. The 20-item Center for Epidemiologic Studies Depression Scale (CES-D) was used to assess depressive symptoms at baseline and use of antidepressants. Five CES-D groups were created based on the distribution of score in approximate quartiles; the top quartile was split in two such that the top group represented those with a score of ≥16. A total of 6,644 participants were followed for a median of 13 years.

The researchers found that a CES-D ≥16 and antidepressant use each correlated with higher incidence of AF (hazard ratios, 1.34 and 1.32, respectively). These correlations did not differ by race or gender.

"If our findings are affirmed in future studies, especially those that formally assess for clinical depression, then we will need to see if treating depression may, in fact, lower the risk for atrial fibrillation," Garg said in a statement.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Lyme-Bearing Ticks More Widespread in U.S. Than Thought

Lyme-Bearing Ticks More Widespread in U.S. Than Thought

Disease-carrying ticks were detected in 83 counties where they'd never been found before

Availability of Generic Antivirals for Hepatitis B Increasing

Availability of Generic Antivirals for Hepatitis B Increasing

Drop in median price of WHO-prequalified generic tenofovir from $208 to $32 from 2004 to 2016

Visual Function Deficits Up in Developmental Dyslexia

Visual Function Deficits Up in Developmental Dyslexia

Increased prevalence of deficits in visual function versus typically developing school-age children

is free, fast, and customized just for you!




Already a member?

Sign In Now »